For updates and more in-depth analysis from David Fried, please click here.

FORBES: Magazine Article

For updates and more in-depth analysis from Kelly Wright, please click here.

FORBES: Doggy Drug Stock

For updates and more in-depth analysis from Peter Way, please click here.

FORBES: An ETF In The Right Network

For updates and more in-depth analysis from Dan Sullivan, please click here.

FORBES: Zimmer Holdings: Aftermarket Body Parts

For updates and more in-depth analysis from Tom Bishop, please click here.

FORBES: Portfolio Defibrillator

For updates and more in-depth analysis from David Kliff, please click here.

FORBES: Amylin Pharmaceuticals: Diabetes Relief

For updates and more in-depth analysis from Curtis Hesler, please click here.

FORBES: Newmont Mining's Golden Glow

For updates and more in-depth analysis from Gerald and Marvin Appel, please click here.

FORBES: High-Income Junkie

For updates and more in-depth analysis from Michael Markowski's StockDiagnostics, please click here.

FORBES: JCOM's Cash Flow Sends A Message

For updates and more in-depth analysis from Ken Kam and the Marketocracy M100, please click here.

FORBES: Betting On A Boston Scientific Bounce